日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

伊维菌素预防COVID-19：一项采用倾向评分匹配法对223,128名受试者进行的城市前瞻性观察研究

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.21272
Kerr, Lucy; Cadegiani, Flavio A; Baldi, Fernando; Lobo, Raysildo B; Assagra, Washington Luiz O; Proença, Fernando Carlos; Kory, Pierre; Hibberd, Jennifer A; Chamie-Quintero, Juan J
发表日期：2022
文献求助 收藏

Correction: Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

更正：伊维菌素预防 COVID-19：一项采用倾向评分匹配法对 223,128 名受试者进行的城市范围前瞻性观察研究

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.c61
Kerr, Lucy; Cadegiani, Flavio A; Baldi, Fernando; Lobo, Raysildo B; Assagra, Washington Luiz O; Proença, Fernando Carlos; Kory, Pierre; Hibberd, Jennifer A; Chamie-Quintero, Juan J
发表日期：2022
文献求助 收藏

Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects

一项对88012名严格控制人群进行的前瞻性观察研究显示，规律使用伊维菌素预防COVID-19可使COVID-19死亡率降低高达92%，且呈剂量反应关系。

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.28624
Kerr, Lucy; Baldi, Fernando; Lobo, Raysildo; Assagra, Washington Luiz; Proença, Fernando Carlos; Chamie, Juan J; Hibberd, Jennifer A; Kory, Pierre; Cadegiani, Flavio A
发表日期：2022
文献求助 收藏